Potential Hepatoprotective Effect of Matricaria Pubescens on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats
- PMID: 38451246
- DOI: 10.1002/cbdv.202302005
Potential Hepatoprotective Effect of Matricaria Pubescens on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats
Abstract
This study aimed to identify the phytochemical compounds of Matricaria pubescens by LC-MS/MS and evaluate the potential protective effect of its supplementation in high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) in adult rats through modulation of oxidative stress and histopathological changes. Twenty-four male rats were randomly divided into four groups. The first group served as control and received the standard diet. The second group (HFD) received a high-fat diet only (30 % of sheep fat). The third group's (control+MP) animals received a standard diet supplemented with 5 % M. pubescens (w/w). The fourth group (HFD+MP) received a high-fat diet supplemented with 5 % M. pubescens for 16 weeks. LC-MS/MS analysis showed that M. pubescens contains many phytochemical compounds. It was observed that the ethanolic extract of M. pubescens has a higher phenolic content than the aqueous extract. The supplementation of M. pubescens (5 % w/w) to HFD rats decreased significantly (p<0.01) body weight, liver and epididymal adipose tissue relative weights, glycemia, triglycerides (TG), insulin resistance, liver markers, TNF-α, malondialdehyde (MDA), protein carbonyl (PCO), advanced oxidation protein products (AOPP) level, and increased reduced glutathione (GSH) level, glutathione peroxidase (GPx), glutathione-S-transferase (GST), superoxide dismutase (SOD), and catalase activities as well as ameliorated histological alterations through the reduction hepatic lipid deposition and adipocytes hypertrophy compared to the HFD group. We conclude that M. pubescens powder may be effective for correcting hyperglycemia, hypertriglyceridemia, insulin resistance, and liver markers while decreasing inflammation and oxidative stress in the liver of high-fat diet-fed rats.
Keywords: High-fat diet; Insulin resistance; LC–MS/MS; Matricaria pubescens; Oxidative stress.
© 2024 Wiley‐VHCA AG, Zurich, Switzerland.
Similar articles
-
Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.J Oleo Sci. 2019 Jun 6;68(6):581-589. doi: 10.5650/jos.ess19018. Epub 2019 May 16. J Oleo Sci. 2019. PMID: 31092797
-
Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease (NAFLD) in rats.Horm Mol Biol Clin Investig. 2020 Feb 14;41(1):/j/hmbci.2020.41.issue-1/hmbci-2019-0040/hmbci-2019-0040.xml. doi: 10.1515/hmbci-2019-0040. Horm Mol Biol Clin Investig. 2020. PMID: 32083445
-
Supplementation of cumin seed powder prevents oxidative stress, hyperlipidemia and non-alcoholic fatty liver in high fat diet fed rats.Biomed Pharmacother. 2021 Sep;141:111908. doi: 10.1016/j.biopha.2021.111908. Epub 2021 Jul 10. Biomed Pharmacother. 2021. PMID: 34328087
-
Erica multiflora extract rich in quercetin-3-O-glucoside and kaempferol-3-O-glucoside alleviates high fat and fructose diet-induced fatty liver disease by modulating metabolic and inflammatory pathways in Wistar rats.J Nutr Biochem. 2020 Dec;86:108490. doi: 10.1016/j.jnutbio.2020.108490. Epub 2020 Sep 11. J Nutr Biochem. 2020. PMID: 32920086
-
Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.Nutrients. 2017 Jul 18;9(7):766. doi: 10.3390/nu9070766. Nutrients. 2017. PMID: 28718838 Free PMC article.
Cited by
-
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23. Arch Toxicol. 2025. PMID: 39443317 Free PMC article. Review.
-
Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.Antioxidants (Basel). 2024 Nov 28;13(12):1461. doi: 10.3390/antiox13121461. Antioxidants (Basel). 2024. PMID: 39765791 Free PMC article. Review.
References
-
- A. M. Matias, W. M. Estevam, P. M. Coelho, D. Haese, J. Kobi, A. P. Lima-Leopoldo, A. S. Leopoldo, Nutrients 2018, 10, 1071.
-
- R. S. Bhat, K. K. Chandrul, A. El-Ansary, Int. J. Mol. Cell. Med. 2016, 5, 149–159.
-
- R. S. Bhat, S. Al-Daihan, Trop. J. Pharm. Res. 2016, 15, 709–716.
-
- R. Shafi, K. K. Chandrul, Int. J. Pharm. Sci. Res. 2017, 8, 3049–3056.
-
- S. Al-Daihan, A. Ben Bacha, A. M. Al-Dbass, M. A. Alonazi, R. S. Bhat, Cell. Mol. Biol. 2018, 64, 103–106.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous